Skip to content

13F-HR filed by Krensavage Asset Management, LLC

Krensavage Asset Management, LLC filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-14, with 10 holding rows worth $308,112,000.

Accession
0001609251-19-000006
Filed
2019-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2019

A holdings report, 10 entries on the cover page, a total value of $308,112,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $308,111,000 with VALUE read as thousands by filing date, 13F file number 028-16807. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MCKESSON CORP COM58155Q103Stock373,297$50,167,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock550,299$42,956,000thousands by filing date
BIOGEN INC COM09062X103Stock176,556$41,291,000thousands by filing date
ENANTA PHARMACEUTICALS INC29251M106COM479,576$40,467,000thousands by filing date
Amgen Inc.031162100COM215,402$39,694,000thousands by filing date
Gilead Sciences,Inc.375558103COM551,237$37,242,000thousands by filing date
ELANCO ANIMAL HEALTH INC COM28414H103Stock891,851$30,145,000thousands by filing date
RTI BIOLOGICS INC74975N105COM3,917,744$16,650,000thousands by filing date
INVACARE CORP461203101COMMON STOCK1,331,409$6,910,000thousands by filing date
AVANOS MED INC05350V106COM59,378$2,589,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001609251-19-000006this filing2019-08-14acceptance time not in the bulk data set